Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Goserelin acetate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zoladex LA 10.8mg implant SafeSystem pre-filled syringes
0803042K0BBABAB
|
Zoladex | Goserelin acetate | Malignant Disease and Immunosuppression | 31,284 |
|
Zoladex 3.6mg implant SafeSystem pre-filled syringes
0803042K0BBAAAA
|
Zoladex | Goserelin acetate | Malignant Disease and Immunosuppression | 26,948 |
|
Goserelin 10.8mg implant pre-filled syringes
0803042K0AAABAB
|
Goserelin acetate | Goserelin acetate | Malignant Disease and Immunosuppression | 14,514 |
|
Goserelin 3.6mg implant pre-filled syringes
0803042K0AAAAAA
|
Goserelin acetate | Goserelin acetate | Malignant Disease and Immunosuppression | 11,477 |
|
Novgos 3.6mg implant pre-filled syringes
0803042K0BCAAAA
|
Novgos | Goserelin acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.